Role of [18F]-dopa-PET imaging in assessing movement disorders
- PMID: 15693650
- DOI: 10.1016/j.rcl.2004.08.002
Role of [18F]-dopa-PET imaging in assessing movement disorders
Abstract
FD-PET has proved to be an extremely useful technique for the noninvasive evaluation of nigrostriatal pathophysiology in patients with PD and other movement disorders. The development of ratio methods for image analysis has greatly reduced the complexity of these PET studies and has facilitated data analysis. With the recent advances in cyclotron targetry and automated synthesis modules FD-PET will soon become an important component of the clinical armamentarium.
Similar articles
-
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.Neurophysiol Clin. 2001 Oct;31(5):321-40. doi: 10.1016/s0987-7053(01)00273-8. Neurophysiol Clin. 2001. PMID: 11817273 Review.
-
Do dopamine agonists or levodopa modify Parkinson's disease progression?Eur J Neurol. 2002 Nov;9 Suppl 3:15-22. doi: 10.1046/j.1468-1331.9.s3.2.x. Eur J Neurol. 2002. PMID: 12464117 Review.
-
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET.J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):256. doi: 10.1136/jnnp.66.2.256. J Neurol Neurosurg Psychiatry. 1999. PMID: 10071122 Free PMC article. No abstract available.
-
Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders.Hell J Nucl Med. 2016 Jan-Apr;19(1):33-41. doi: 10.1967/s002449910335. Epub 2016 Mar 1. Hell J Nucl Med. 2016. PMID: 26929938 Review.
-
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.Mov Disord. 2006 Jul;21(7):958-63. doi: 10.1002/mds.20855. Mov Disord. 2006. PMID: 16550545
Cited by
-
Automatic Production of [18F]F-DOPA Using the Raytest SynChrom R&D Module.Pharmaceuticals (Basel). 2022 Dec 22;16(1):10. doi: 10.3390/ph16010010. Pharmaceuticals (Basel). 2022. PMID: 36678506 Free PMC article.
-
Abnormal striatal dopamine transmission in schizophrenia.Curr Med Chem. 2013;20(3):397-404. doi: 10.2174/0929867311320030011. Curr Med Chem. 2013. PMID: 23157632 Free PMC article. Review.
-
The sensitivity and specificity of F-DOPA PET in a movement disorder clinic.Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):102-9. eCollection 2016. Am J Nucl Med Mol Imaging. 2016. PMID: 27069770 Free PMC article.
-
Green and efficient synthesis of the radiopharmaceutical [18F]FDOPA using a microdroplet reactor.React Chem Eng. 2020 Feb 1;5(2):320-329. doi: 10.1039/c9re00354a. Epub 2019 Dec 13. React Chem Eng. 2020. PMID: 34164154 Free PMC article.
-
Brain positron emission tomography with 2-18F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.Neuroradiol J. 2018 Feb;31(1):60-68. doi: 10.1177/1971400917719912. Epub 2017 Aug 14. Neuroradiol J. 2018. PMID: 28805131 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical